Mitochondrial genetic background modifies breast cancer risk

被引:193
作者
Bai, Ren-Kui
Leal, Suzanne M.
Covarrubias, Daniel
Liu, Aiyi
Wong, Lee-Jun C.
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Rice Univ, Dept Stat, Houston, TX 77251 USA
[3] NICHHD, Biometry & Math Stat Branch, NIH, Rockville, MD USA
关键词
D O I
10.1158/0008-5472.CAN-06-3554
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inefficient mitochondrial electron transport chain (ETC) function has been implicated in the vicious cycle of reactive oxygen species (ROS) production that may predispose an individual to late onset diseases, such as diabetes, hypertension, and cancer. Mitochondrial DNA (mtDNA) variations may affect the efficiency of ETC and ROS production, thus contributing to cancer risk. To test this hypothesis, we genotyped 69 mtDNA variations in 156 unrelated European-American females with familial breast cancer and 260 age-matched European-American female controls. Fisher's exact test was done for each single-nucleotide polymorphism (SNP)/haplogroup and the P values were adjusted for multiple testing using permutation. Odds ratio (OR) and its 95% confidence interval (95% CI) were calculated using the Sheehe correction. Among the 69 variations, 29 were detected in the study subjects. Three SNPs, G9055A (OR, 3.03; 95% CI, 1.63-5.63; P = 0.0004, adjusted P = 0.0057), A10398G (OR, 1.79; 95% CI, 1.14-2.81; P = 0.01, adjusted P = 0.19), and T16519C (OR, 1.98; 95% CI, 1.25-3.12; P = 0.0030, adjusted P = 0.0366), were found to increase breast cancer risk, whereas T3197C (OR, 0.31; 95% CI, 0.13-0.75; P = 0.0043, adjusted P = 0.0526) and G13708A (OR, 0.47; 95% CI, 0.24-0.92; P = 0.022, adjusted P = 0.267) were found to decrease breast cancer risk. Overall, individuals classified as haplogroup K show a significant increase in the risk of developing breast cancer (OR, 3.03; 95% CI, 1.63-5.63; P = 0.0004, adjusted P = 0.0057), whereas individuals bearing haplogroup U have a significant decrease in breast cancer risk (OR, 0.37; 95% CI, 0.19-0.73; P = 0.0023, adjusted P = 0.03). Our results suggest that mitochondrial genetic background plays a role in modifying an individual's risk to breast cancer.
引用
收藏
页码:4687 / 4694
页数:8
相关论文
共 51 条
[1]  
Ambrosone CB, 1999, CANCER RES, V59, P602
[2]   Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia [J].
Autere, J ;
Moilanen, JS ;
Finnilä, S ;
Soininen, H ;
Mannermaa, A ;
Hartikainen, P ;
Hallikainen, M ;
Majamaa, K .
HUMAN GENETICS, 2004, 115 (01) :29-35
[3]   Median-joining networks for inferring intraspecific phylogenies [J].
Bandelt, HJ ;
Forster, P ;
Röhl, A .
MOLECULAR BIOLOGY AND EVOLUTION, 1999, 16 (01) :37-48
[4]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[5]   MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population [J].
Behar, DM ;
Hammer, MF ;
Garrigan, D ;
Villems, R ;
Bonne-Tamir, B ;
Richards, M ;
Gurwitz, D ;
Rosengarten, D ;
Kaplan, M ;
Della Pergola, S ;
Quintana-Murci, L ;
Skorecki, K .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (05) :355-364
[6]   ROS, stress-activated kinases and stress signaling in cancer [J].
Benhar, M ;
Engelberg, D ;
Levitzki, A .
EMBO REPORTS, 2002, 3 (05) :420-425
[7]   North American white mitochondrial haplogroups in prostate and renal cancer [J].
Booker, LM ;
Habermacher, GM ;
Jessie, BC ;
Sun, QC ;
Baumann, AK ;
Amin, M ;
Lim, SD ;
Fernandez-Golarz, C ;
Lyles, RH ;
Brown, MD ;
Marshall, FF ;
Petros, JA .
JOURNAL OF UROLOGY, 2006, 175 (02) :468-472
[8]  
BOOKER LM, 2006, J UROLOGY, V175, P72
[9]   Mitochondrial mutations in cancer [J].
Brandon, M. ;
Baldi, P. ;
Wallace, D. C. .
ONCOGENE, 2006, 25 (34) :4647-4662
[10]   The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J [J].
Brown, MD ;
Starikovskaya, E ;
Derbeneva, O ;
Hosseini, S ;
Allen, JC ;
Mikhailovskaya, IE ;
Sukernik, RI ;
Wallace, DC .
HUMAN GENETICS, 2002, 110 (02) :130-138